{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:22:21Z","timestamp":1794270141956,"version":"4.9.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI21\/000509"],"award-info":[{"award-number":["PI21\/000509"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI25\/00018"],"award-info":[{"award-number":["PI25\/00018"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijantimicag.2026.107955","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:09:13Z","timestamp":1786374553000},"page":"107955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of an antimicrobial stewardship intervention on clinical and economic outcomes in outpatient parenteral antimicrobial therapy (OPAT) for urinary tract infections: A quasi-experimental study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5987-068X","authenticated-orcid":false,"given":"Silvia","family":"G\u00f3mez-Zorrilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8799-1606","authenticated-orcid":false,"given":"Rosa Ana","family":"Sabat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"L\u00f3pez Montesinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5372-9622","authenticated-orcid":false,"given":"Ariadna","family":"Bras\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3697-2552","authenticated-orcid":false,"given":"Alicia","family":"Rodr\u00edguez-Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Echeverr\u00eda-Esnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2784-6914","authenticated-orcid":false,"given":"Grethel","family":"Rodr\u00edguez-Cabale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"L\u00f3pez Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5759-4853","authenticated-orcid":false,"given":"Elisabeth","family":"Lafuente Cabrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Garc\u00eda-Alzorriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Cots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Dur\u00e1n-Jord\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8428-1836","authenticated-orcid":false,"given":"Santiago","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9562-514X","authenticated-orcid":false,"given":"Luisa","family":"Sorli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Horcajada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6732-9001","authenticated-orcid":false,"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107955_bib0001","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy745","article-title":"Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy","volume":"68","author":"Norris","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijantimicag.2026.107955_bib0002","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s15010-018-1250-1","article-title":"Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?","volume":"47","author":"Steffens","year":"2019","journal-title":"Infection"},{"issue":"6","key":"10.1016\/j.ijantimicag.2026.107955_bib0003","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/cid\/ciz362","article-title":"Quality indicators for appropriate outpatient parenteral antimicrobial therapy in adults: a systematic review and RAND-modified Delphi procedure","volume":"70","author":"Berrevoets","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107955_bib0004","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijantimicag.2017.02.017","article-title":"Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain","volume":"50","author":"Gonz\u00e1lez-Ramallo","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107955_bib0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/14737167.2017.1360767","article-title":"Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review","volume":"17","author":"Psaltikidis","year":"2017","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107955_bib0006","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12913-024-11017-9","article-title":"Exploring patients' perspectives: a mixed methods study on outpatient parenteral antimicrobial therapy (OPAT) experiences","volume":"24","author":"Peter","year":"2024","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"10.1016\/j.ijantimicag.2026.107955_bib0007","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00345-021-03913-0","article-title":"Global, regional, and national burden of urinary tract infections from 1990 to 2019: an analysis of the global burden of disease study 2019","volume":"40","author":"Zeng","year":"2022","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107955_bib0008","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1007\/s40121-021-00537-0","article-title":"A large multicenter prospective study of community-onset healthcare-associated bacteremic urinary tract infections in the era of multidrug resistance: even worse than hospital-acquired infections?","volume":"10","author":"G\u00f3mez-Zorrilla","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"10459","key":"10.1016\/j.ijantimicag.2026.107955_bib0009","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ijantimicag.2026.107955_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11908-021-00766-x","article-title":"Recent updates in antimicrobial stewardship in outpatient parenteral antimicrobial therapy","volume":"23","author":"Mahoney","year":"2021","journal-title":"Curr Infect Dis Rep"},{"issue":"7","key":"10.1016\/j.ijantimicag.2026.107955_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae347","article-title":"Antimicrobial stewardship practices in outpatient parenteral antimicrobial therapy programs in the United States","volume":"11","author":"Azimi","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107955_bib0012","series-title":"EAU Guidelines","article-title":"EAU Guidelines on Urological Infections","author":"Bonkat","year":"2025"},{"key":"10.1016\/j.ijantimicag.2026.107955_bib0013","article-title":"Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Timing of Intravenous to Oral Antibiotics Transition for Complicated UTI","volume":"19","author":"Trautner","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107955_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00003-20","article-title":"The five ds of outpatient antibiotic stewardship for urinary tract infections","volume":"34","author":"Goebel","year":"2021","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"10.1016\/j.ijantimicag.2026.107955_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.44495","article-title":"Guidelines for the prevention, diagnosis, and management of urinary tract infections in pediatrics and adults: a WikiGuidelines Group Consensus Statement","volume":"7","author":"Nelson","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijantimicag.2026.107955_bib0016","series-title":"Shorter is better","author":"Spellberg","year":"2026"},{"issue":"3","key":"10.1016\/j.ijantimicag.2026.107955_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.1421","article-title":"Seven vs fourteen days of antibiotics for gram-negative bloodstream infection: a systematic review and noninferiority meta-analysis","volume":"8","author":"Lee","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.ijantimicag.2026.107955_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068299","article-title":"Criteria to achieve safe antimicrobial intravenous-to-oral switch in hospitalised adult populations: a systematic rapid review","volume":"13","author":"Harvey","year":"2023","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107955_bib0019","article-title":"IV versus oral stepdown for GN complicated UTI with bacteremia","volume":"11","author":"Veillette","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107955_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jgar.2019.03.013","article-title":"Comparison of intravenous and oral definitive antibiotic regimens in hospitalised patients with Gram-negative bacteraemia from a urinary tract infection","volume":"18","author":"Thurber","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2026.107955_bib0021","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microb Infect"},{"key":"10.1016\/j.ijantimicag.2026.107955_bib0022","article-title":"Infectious Diseases Society of America 2024 Guidance on the treatment of antimicrobial-resistant gram-negative infections","volume":"7","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ijantimicag.2026.107955_bib0023","article-title":"Safety and efficacy of midline vs peripherally inserted central catheters among adults receiving IV therapy: a randomized clinical trial","volume":"5","author":"Thomsen","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.ijantimicag.2026.107955_bib0024","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/NAN.0000000000000559","article-title":"The midline catheter within the context of home intravenous antibiotic treatment","volume":"47","author":"Lafuente Cabrero","year":"2024","journal-title":"J Infus Nurs"},{"key":"10.1016\/j.ijantimicag.2026.107955_bib0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"key":"10.1016\/j.ijantimicag.2026.107955_bib0026","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1748-5908-7-37","article-title":"Validation of the theoretical domains framework for use in behaviour change and implementation research","volume":"7","author":"Cane","year":"2012","journal-title":"Implement Sci"},{"key":"10.1016\/j.ijantimicag.2026.107955_bib0027","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1748-5908-8-35","article-title":"A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice","volume":"8","author":"Flottorp","year":"2013","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107955_bib0028","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12160-013-9486-6","article-title":"The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behaviour change interventions","volume":"46","author":"Michie","year":"2013","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.ijantimicag.2026.107955_bib0029","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic in longitudinal studies: development","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijantimicag.2026.107955_bib0030","first-page":"61","article-title":"Functional evaluation: the Barthel Index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Maryland State Med J"},{"key":"10.1016\/j.ijantimicag.2026.107955_bib0031","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/CCM.0b013e31819def97","article-title":"The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation","volume":"37","author":"Jones","year":"2010","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ijantimicag.2026.107955_bib0032","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107955_bib0033","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s15010-024-02194-0","article-title":"Improving antimicrobial treatment in terms of antimicrobial stewardship and health costs by an OPAT service","volume":"52","author":"Burch","year":"2024","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107955_bib0034","article-title":"Rate of broad-spectrum antibiotic overuse in patients receiving outpatient parenteral antibiotic therapy (OPAT)","volume":"1","author":"Brenon","year":"2021","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"9","key":"10.1016\/j.ijantimicag.2026.107955_bib0035","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/jac\/dkae177","article-title":"Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review","volume":"79","author":"Wolie","year":"2024","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107955_bib0036","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1186\/s12879-021-06458-0","article-title":"Retrospective assessment of antimicrobial stewardship initiative in outpatient use of ertapenem for uncomplicated extended spectrum beta lactamase Enterobacteriaceae urinary tract infections","volume":"21","author":"Wong","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107955_bib0037","article-title":"Impact of a pharmacist-managed outpatient parenteral antimicrobial therapy (OPAT) service on cost savings and clinical outcomes at an academic medical center","volume":"3","author":"Epperson","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"6","key":"10.1016\/j.ijantimicag.2026.107955_bib39","doi-asserted-by":"crossref","first-page":"107787","DOI":"10.1016\/j.ijantimicag.2026.107787","article-title":"ESBL-producing Escherichia coli bacteraemic urinary tract infections: Clinical and economic burden and antimicrobial stewardship opportunities in a retrospective cohort study","volume":"67","author":"G\u00f3mez-Zorrilla","year":"2026","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"10.1016\/j.ijantimicag.2026.107955_bib0038","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/jac\/dkad234","article-title":"Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)","volume":"78","author":"Becerra-Aparicio","year":"2023","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:39:31Z","timestamp":1794267571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926002426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0924857926002426"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107955","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of an antimicrobial stewardship intervention on clinical and economic outcomes in outpatient parenteral antimicrobial therapy (OPAT) for urinary tract infections: A quasi-experimental study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107955"}}